Deferitazole magnesium

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameDeferitazole magnesium
Drug Alias NameDeferitazolum去铁他唑镁迪非他唑镁SSP-004184AQSSP-004184SS +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIron chelating agents
TargetsNot applicable
Therapy Area/IndicationsHemosiderosisIron OverloadIron Metabolism Disorders +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesThailand +[9] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesShire Development Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShireFerrokin Biosciences Inc
Active IndicationsN/A
Inactive IndicationsHemosiderosisIron OverloadIron Metabolism Disorders +[7] 

Other Information

ATC CodeN/A
Related LinksKEGG